Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of a Single Dose of Intravenous MK-0517 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Cisplatin Chemotherapy
Brief Summary: The purpose of this study is to examine the safety, tolerability, and efficacy of MK0517 to prevent Chemotherapy-Induced Nausea and Vomiting (CINV) associated with Cisplatin chemotherapy.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Comparator: fosaprepitant dimeglumine, Drug: Dexamethasone, Drug: Ondansetron | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: Aprepitant, Drug: Dexamethasone, Drug: Ondansetron | Intervention Type: DRUG; Name: Comparator: fosaprepitant dimeglumine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Comparator: Aprepitant; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): 1, 2
B: Arm Label: metoclopramide; Type: ACTIVE_COMPARATOR; Interventions: Drug: metoclopramide | Arm Label: dexamethason; Type: ACTIVE_COMPARATOR; Interventions: Drug: dexamethason | Arm Label: palonosetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: palonosetron | Intervention Type: DRUG; Name: metoclopramide; Assigned to Arm(s): metoclopramide | Intervention Type: DRUG; Name: dexamethason; Assigned to Arm(s): dexamethason | Intervention Type: DRUG; Name: palonosetron; Assigned to Arm(s): palonosetron
C: Arm Label: SCH 619734 Dose 1; Type: EXPERIMENTAL; Interventions: Drug: SCH 619734 Dose 1 | Arm Label: SCH 619734 Dose 2; Type: EXPERIMENTAL; Interventions: Drug: SCH 619734 Dose 2 | Arm Label: SCH 619734 Dose 3; Type: EXPERIMENTAL; Interventions: Drug: SCH 619734 Dose 3 | Arm Label: SCH 619734 Dose 4; Type: EXPERIMENTAL; Interventions: Drug: SCH 619734 Dose 4 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SCH 619734 Dose 1; Assigned to Arm(s): SCH 619734 Dose 1 | Intervention Type: DRUG; Name: SCH 619734 Dose 2; Assigned to Arm(s): SCH 619734 Dose 2 | Intervention Type: DRUG; Name: SCH 619734 Dose 3; Assigned to Arm(s): SCH 619734 Dose 3 | Intervention Type: DRUG; Name: SCH 619734 Dose 4; Assigned to Arm(s): SCH 619734 Dose 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Aprepitant Regimen; Type: EXPERIMENTAL; Interventions: Drug: Aprepitant, Drug: Ondansetron, Drug: Dexamethasone, Drug: Ondansetron Placebo, Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride). | Arm Label: Control Regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aprepitant Placebo, Drug: Ondansetron, Drug: Dexamethasone, Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride). | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant Regimen | Intervention Type: DRUG; Name: Aprepitant Placebo; Assigned to Arm(s): Control Regimen | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Aprepitant Regimen, Control Regimen | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Aprepitant Regimen, Control Regimen | Intervention Type: DRUG; Name: Ondansetron Placebo; Assigned to Arm(s): Aprepitant Regimen | Intervention Type: DRUG; Name: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).; Assigned to Arm(s): Aprepitant Regimen, Control Regimen

Answer: A